{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:12:18Z","timestamp":1780081938608,"version":"3.54.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071519"],"award-info":[{"award-number":["82071519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371519"],"award-info":[{"award-number":["82371519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuropharm.2025.110632","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T14:47:56Z","timestamp":1754750876000},"page":"110632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus participate in the antidepressant-like mechanism of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine in mice"],"prefix":"10.1016","volume":"279","author":[{"given":"Jun-Jie","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Lun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Yang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2025.110632_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/bms.1200081103","article-title":"Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations","volume":"8","author":"Adams","year":"1981","journal-title":"Biomed. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2025.110632_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yfrne.2011.08.002","article-title":"The molecular physiology of CRH neurons","volume":"33","author":"Aguilera","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib3","article-title":"The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice","volume":"13","author":"Anderzhanova","year":"2020","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110632_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2018.12.002","article-title":"Chronic unpredictable mild stress for modeling depression in rodents: meta-Analysis of model reliability","volume":"99","author":"Antoniuk","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110632_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neubiorev.2020.01.011","article-title":"The contagion of social defeat stress: insights from rodent studies","volume":"111","author":"Carnevali","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2025.110632_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115097","article-title":"Hippocampal F3\/Contactin plays a role in chronic stress-induced depressive-like effects and the antidepressant actions of vortioxetine in mice","volume":"202","author":"Chen","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib8","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1074\/jbc.C110.119222","article-title":"Drosophila salt-inducible kinase (SIK) regulates starvation resistance through cAMP-response element-binding protein (CREB)-Regulated transcription coactivator (CRTC)","volume":"286","author":"Choi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2025.110632_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.06.033","article-title":"(2R,6R)-Hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","volume":"139","author":"Chou","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110632_bib10","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1038\/s41380-022-01755-9","article-title":"Inhibition of FKBP51 induces stress resilience and alters hippocampal neurogenesis","volume":"27","author":"Codagnone","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1042\/BCJ20200502","article-title":"Nuts and bolts of the salt-inducible kinases (SIKs)","volume":"478","author":"Darling","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2025.110632_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajp.2017.01.025","article-title":"The neurobiology of depression: an integrated view","volume":"27","author":"Dean","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00498254.2012.685777","article-title":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","volume":"42","author":"Desta","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neuropharm.2025.110632_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0278-5846(01)00161-0","article-title":"Role of endogenous opioid system in the regulation of the stress response","volume":"25","author":"Drolet","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/ejn.15952","article-title":"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R-hydroxynorketamine","volume":"57","author":"Fred","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1073\/pnas.1814709116","article-title":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-Hydroxynorketamine","volume":"116","author":"Fukumoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110632_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jad.2023.04.101","article-title":"2R,6R)-hydroxynorketamine improves PTSD-Associated behaviors and structural plasticity via modulating BDNF-mTOR signaling in the nucleus accumbens","volume":"335","author":"Gou","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110632_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105932","article-title":"Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF","volume":"174","author":"Guan","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2025.110632_bib20","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/jcb.21737","article-title":"Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity","volume":"104","author":"Hashimoto","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2025.110632_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/0269881118812095","article-title":"Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of (2R,6R)-Hydroxynorketamine","volume":"33","author":"Highland","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095796","article-title":"Depletion of FKBP51 in female mice shapes HPA axis activity","volume":"9","author":"Hoeijmakers","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2025.110632_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2025.104006","article-title":"Single subanesthetic dose of ketamine exerts antioxidant and antidepressive-like effect in ACTH-Induced preclinical model of depression","volume":"133","author":"Ivanovi\u0107","year":"2025","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114836","article-title":"Hippocampal MSK1 regulates the behavioral and biological responses of mice to chronic social defeat stress: involving of the BDNF-CREB signaling and neurogenesis","volume":"195","author":"Ji","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bph.13668","article-title":"Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway","volume":"174","author":"Jiang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1021\/acschemneuro.0c00741","article-title":"Ketamine metabolite (2R,6R)-hydroxynorketamine interacts with \u03bc and \u03ba opioid receptors","volume":"12","author":"Joseph","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib29","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/j.1742-4658.2006.05291.x","article-title":"Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling Cascade","volume":"273","author":"Katoh","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2025.110632_bib30","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2025.110632_bib31","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110632_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-444-64123-6.00004-7","article-title":"Hypothalamic-pituitary-adrenal axis and stress","volume":"175","author":"Leistner","year":"2020","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2022.100503","article-title":"2R,6R)-hydroxynorketamine acts through GluA1-induced synaptic plasticity to alleviate PTSD-like effects in rat models","volume":"21","author":"Li","year":"2022","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.neuropharm.2025.110632_bib35","article-title":"The selective SIK2 inhibitor ARN-3236 produces strong antidepressant-like efficacy in mice via the hippocampal CRTC1-CREB-BDNF pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib36","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-Hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110632_bib37","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1021\/acs.orglett.7b02177","article-title":"Synthesis and N-Methyl-d-aspartate (NMDA) receptor activity of ketamine metabolites","volume":"19","author":"Morris","year":"2017","journal-title":"Org. Lett."},{"key":"10.1016\/j.neuropharm.2025.110632_bib38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib39","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib40","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2008.06.006","article-title":"The HPA axis in major depression: classical theories and new developments","volume":"31","author":"Pariante","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib41","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.biopsych.2017.10.020","article-title":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-Hydroxynorketamine-Induced sustained antidepressant-like effects","volume":"84","author":"Pham","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnbeh.2018.00262","article-title":"Pharmacological modulation of the psychiatric risk factor FKBP51 alters efficiency of common antidepressant drugs","volume":"12","author":"P\u00f6hlmann","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16091144","article-title":"Comparative efficacy of animal depression models and antidepressant treatment: a systematic review and meta-analysis","volume":"16","author":"Ratajczak","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.neuropharm.2025.110632_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1152\/jn.00326.2023","article-title":"cAMP-dependent protein kinase signaling is required for (2R,6R)-Hydroxynorketamine to potentiate hippocampal glutamatergic transmission","volume":"131","author":"Riggs","year":"2024","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib45","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u2217D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jad.2023.05.085","article-title":"The antidepressant-like effects of escitalopram in mice require salt-inducible kinase 1 and CREB-Regulated transcription co-activator 1 in the paraventricular nucleus of the hypothalamus","volume":"338","author":"Shi","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2025.110632_bib47","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib48","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/bph.14346","article-title":"Hippocampal PPAR\u03b1 is a novel therapeutic target for depression and mediates the antidepressant actions of fluoxetine in mice","volume":"175","author":"Song","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib49","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature22084","article-title":"Effects of a ketamine metabolite on synaptic NMDAR function","volume":"546","author":"Suzuki","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110632_bib50","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.psyneuen.2008.12.012","article-title":"The effect of antidepressant drugs on the HPA axis activity, glucocorticoid receptor level and FKBP51 concentration in prenatally stressed rats","volume":"34","author":"Szyma\u0144ska","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2025.110632_bib51","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/j.1742-4658.2007.05889.x","article-title":"TORC-SIK Cascade regulates CREB activity through the basic leucine zipper domain","volume":"274","author":"Takemori","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2025.110632_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsbmb.2007.09.006","article-title":"Regulation of CREB-Mediated gene expression by salt inducible kinase","volume":"108","author":"Takemori","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114885","article-title":"Virus-mediated decrease of LKB1 activity in the mPFC diminishes stress-induced depressive-like behaviors in mice","volume":"197","author":"Tang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR\u2217D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrn2647","article-title":"Neural regulation of endocrine and autonomic stress responses","volume":"10","author":"Ulrich-Lai","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib56","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(01)00294-9","article-title":"The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade","volume":"26","author":"Wand","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2025.110632_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115273","article-title":"2R, 6R)-hydroxynorketamine ameliorates PTSD-Like behaviors during the reconsolidation phase of fear memory in rats by modulating the VGF\/BDNF\/GluA1 signaling pathway in the hippocampus","volume":"476","author":"Wang","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110632_bib58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/cns.12708","article-title":"Antidepressant-like effects of tetrahydroxystilbene glucoside in mice: involvement of BDNF signaling Cascade in the hippocampus","volume":"23","author":"Wang","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2025.110632_bib59","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbr.2019.01.057","article-title":"Ketamine improved depressive-like behaviors via hippocampal glucocorticoid receptor in chronic stress induced- susceptible mice","volume":"364","author":"Wang","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2025.110632_bib60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1037\/bne0000418","article-title":"Chronic social defeat stress mouse model: current view on its behavioral deficits and modifications","volume":"135","author":"Wang","year":"2021","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2025.110632_bib61","article-title":"Hippocampal PPAR\u03b1 plays a role in the pharmacological mechanism of vortioxetine, a multimodal-acting antidepressant","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2025.110632_bib62","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s41380-022-01881-4","article-title":"Salt-inducible kinase 1-CREB-regulated transcription coactivator 1 signalling in the paraventricular nucleus of the hypothalamus plays a role in depression by regulating the hypothalamic-pituitary-adrenal axis","volume":"29","author":"Wang","year":"2024","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2025.110632_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(99)00708-5","article-title":"Cloning of a novel kinase (SIK) of the SNF1\/AMPK family from high salt diet-treated rat adrenal","volume":"453","author":"Wang","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2025.110632_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108984","article-title":"Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions","volume":"208","author":"Ye","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2025.110632_bib65","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-Hydroxynorketamine exerts mGlu(2) receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2025.110632_bib66","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2025.110632_bib67","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2025.110632_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2012.03.004","article-title":"Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression","volume":"72","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2025.110632_bib69","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390825003405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:15:55Z","timestamp":1780028155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390825003405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":69,"alternative-id":["S0028390825003405"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110632","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus participate in the antidepressant-like mechanism of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2025.110632","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110632"}}